` LBPH (Longboard Pharmaceuticals Inc) vs S&P 500 Comparison - Alpha Spread

LBPH
vs
S&P 500

Over the past 12 months, LBPH has significantly outperformed S&P 500, delivering a return of 188% compared to the S&P 500's 10% growth.

Stocks Performance
LBPH vs S&P 500

Loading
LBPH
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
LBPH vs S&P 500

Loading
LBPH
S&P 500
Difference
www.alphaspread.com

Performance By Year
LBPH vs S&P 500

Loading
LBPH
S&P 500
Add Stock

Competitors Performance
Longboard Pharmaceuticals Inc vs Peers

S&P 500
LBPH
LLY
JNJ
NOVO B
ROG
Add Stock

Longboard Pharmaceuticals Inc
Glance View

Market Cap
2.3B USD
Industry
Pharmaceuticals

Nestled in the bustling biotech landscape, Longboard Pharmaceuticals Inc. has carved its niche by steering its focus toward developing transformative therapies for neurological diseases. Born from the strategic insights honed within Arena Pharmaceuticals, Longboard carries forward an unwavering commitment to unraveling the complexities of neurobiology. At its core, the company's research is laser-focused on advancing a robust pipeline, notably targeting conditions with high unmet needs such as epilepsy and other neuropsychiatric disorders. The cornerstone of their approach lies in leveraging cutting-edge science to target specific neurological pathways, thus fostering innovative drug candidates that hold the potential to redefine treatment paradigms. The financial engine of Longboard turns primarily on its potential to bring successful therapies to market. Like many firms in the biotech sector, its journey from the lab bench to patient bedside is fraught with substantial R&D investments, clinical trial navigation, and regulatory hurdles. The promise of substantial returns hinges on achieving significant breakthroughs, securing FDA approval, and eventually commercializing their therapies. Additional revenue streams might emerge through strategic partnerships, collaborations, and licensing agreements with other pharmaceutical entities, which can provide both immediate funding and shared resources to propel their products forward. Ultimately, Longboard’s financial health is intertwined with its scientific progress and regulatory milestones, painting a picture of a company deeply embedded in the rhythms of innovation and impact-driven healthcare solutions.

LBPH Intrinsic Value
Not Available
Back to Top